Researchers find changes in blood proteins up to two years before breast cancer diagnosis

breast cancer
Credit: Pixabay/CC0 Public Domain

Researchers have found changes in the levels of particular proteins in people's blood up to two years before they were diagnosed with breast cancer.

The study, presented today (Wednesday) at the 13th European Breast Cancer Conference, could form the basis of blood testing for people with a or a family history of to ensure the disease is diagnosed early when the chances of survival are greatest.

The findings, presented by Sophie Hagenaars from Leiden University Medical Center in The Netherlands, are from the Trial Early Serum Test Breast cancer (TESTBREAST) study.

The TESTBREAST study was initiated in 2011 by Professor Rob Tollenaar and Dr. Wilma Mesker, and currently includes 1174 women who are at a high risk of breast cancer, due to their family history or because they carry gene variants that are known to raise their . The women are being cared for at nine hospitals across The Netherlands where they are offered breast screening at a younger age and more regularly than the rest of the Dutch population who have an average risk of breast cancer.

The study has been running for ten years and the women taking part have been giving blood samples at least once a year when they go for screening. Any who develop breast cancer also give samples at the time of diagnosis.

Researchers used a well-established technique called to analyze the levels of different proteins in the women's blood. They looked both for variation between different women and changes that emerge in individual women over time.

So far, the researchers have made detailed analyses of 30 blood samples taken over time from three women who have been diagnosed with breast cancer and three women who have not developed breast cancer, and found distinct differences between the women over time. This has revealed a set of six proteins that were at higher or lower levels one to two years prior to diagnosis.

Hagenaars said, "These proteins could form the basis for a for early detection of breast cancer in women at a higher risk. It's important to note that we found more variation in the levels in the between women, compared to over time within the same woman who developed breast cancer. This shows that testing should probably be based both on proteins that differ between women with and without breast cancer and on proteins that alter in an individual person over time."

The researchers will now validate their findings in a larger group of women with and without breast cancer taking part in the TESTBREAST study and in taking part in other high-risk breast cancer research studies. Hagenaars added, "If further research validates our findings, this testing could be used as an add-on to existing screening techniques. Blood tests are relatively simple and not particularly painful for most people, so people could be offered screening as often as needed."

Dr. Laura Biganzoli is Co-Chair of the European Breast Cancer Conference and Director of the Breast Center at Santo Stefano Hospital, Prato, Italy, and was not involved in the research. She said, "Women at a high risk of developing breast cancer take part in screening programs at fixed time-points. If this research ultimately results in a blood test for people with a high risk of breast cancer, that could guide personalized screening and help to diagnose breast cancer at the earliest possible stage."

More information: Conference:

Provided by European Organisation for Research and Treatment of Cancer
Citation: Researchers find changes in blood proteins up to two years before breast cancer diagnosis (2022, November 16) retrieved 10 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

What is a mammogram, and why are they important?


Feedback to editors